共 70 条
[1]
Kwon BS(2021)Progressive fibrosing interstitial lung disease: prevalence and clinical outcome Respir Res 22 282-24
[2]
Choe J(2019)Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management Curr Med Res Opin 35 2015-27
[3]
Chae EJ(2021)Predictors for progressive fibrosis in patients with connective tissue disease associated interstitial lung diseases Respir Med 187 106579-60
[4]
Hwang HS(2019)Nintedanib in Progressive Fibrosing interstitial lung Diseases N Engl J Med 381 1718-9
[5]
Kim YG(2019)Rheumatoid Arthritis-Associated interstitial lung disease: clinical characteristics and predictors of Mortality Respiration 98 455-60
[6]
Song JW(2017)Recent advances in the pathogenesis, prediction, and management of rheumatoid arthritis-associated interstitial lung disease Curr Opin Rheumatol 29 254-83
[7]
Wijsenbeek M(2020)Risk factors, and biomarkers in systemic sclerosis with interstitial lung disease Am J Respir Crit Care Med 201 650-45
[8]
Kreuter M(2019)Imaging patterns are Associated with interstitial lung abnormality progression and mortality Am J Respir Crit Care Med 200 175-8
[9]
Olson A(2017)2016 American College of Rheumatology/European League against Rheumatism classification criteria for primary Sjogren’s syndrome: a Consensus and Data-Driven Methodology Involving Three International Patient cohorts Arthritis Rheumatol 69 35-36
[10]
Chiu YH(2002)Classification criteria for Sjogren’s syndrome: a revised version of the european criteria proposed by the american-european Consensus Group Ann Rheum Dis 61 554-14